CompletedNot Applicable

Protective Effect of Biodegradable Collagen Implant (Ologen) in Scleral Thinning After Strabismus Surgery

South Korea20 participantsStarted 2015-09-30

Plain-language summary

This study is to investigate protective effect of biodegradable collagen implant in scleral showing after lateral rectus recession in patients with exotropia.

Who can participate

Age range10 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with intermittent exotropia or constant exotropia
✓. Alternate prism cover test showed 20 prism diopters or more than 20 prism diopters exotropia
✓. Subjects who want to do strabismus surgery

Exclusion criteria

✕. Subject who had previous strabismus surgery or other ocular surgery history
✕. Thyroid eye disease or other connective tissue disease
✕. Significant bleeding or scleral perforation during operation
✕. Subjects who need to do medial rectus resection, not lateral rectus recession
✕. Subjects who had a plan to do other intra or extraocular surgery within 3 months

What they're measuring

Scleral thinning assessed with slit photography

Timeframe: Postoperative 3 months

Trial details

NCT IDNCT02699580

SponsorYonsei University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-09-10

View on ClinicalTrials.gov More Exotropia or Intermittent Exotropia trials